Loading clinical trials...
Loading clinical trials...
Phase IV, Proof of Concept Study to Evaluate Tysabri Effectiveness in RRMS Patient Bladder Function
Conditions
Interventions
BG0002 (natalizumab)
Start Date
March 1, 2009
Primary Completion Date
March 1, 2011
Completion Date
March 1, 2011
Last Updated
June 27, 2014
NCT05758831
NCT06586177
NCT05906992
NCT05755061
NCT01805336
NCT04940065
Lead Sponsor
Biogen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions